| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $356.3M | +26.8% |
| R&D Expense | $112.3M | +23.1% |
| SG&A Expense | $79.9M | -0.6% |
| Operating Income | -$136.5M | +22.7% |
| Interest Expense | $1.9M | +31.4% |
| Pre-tax Income | -$135.3M | +23.0% |
| Income Tax | $1.5M | +219.5% |
| Net Income | -$136.9M | +22.3% |
| EPS (Basic) | -$2.51 |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $87.5M | -50.5% |
| Accounts Receivable | $64.9M | +26.2% |
| Current Assets | $195.7M | -25.4% |
| Total Assets | $370.3M | +0.1% |
| Current Liabilities | $110.1M | +39.3% |
| Long-term Debt | $3.1M | +1179.3% |
| Total Liabilities | $118.9M | +44.6% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$32.4M | +64.1% |
| Capital Expenditures | $5.8M | +22.7% |
| Investing Cash Flow | -$39.7M | -51.4% |
| Financing Cash Flow | -$17.1M | +17.7% |
| Free Cash Flow | -$38.2M | +59.7% |
| +25.3% |
| EPS (Diluted) | -$2.51 | +25.3% |
| Stockholders' Equity |
| $251.4M |
| -12.6% |